University of Cologne scientists identified histone H1.2 and PARP1 as potential therapeutic targets in ALS. Inhibiting these proteins reduced neurodegeneration in both human motor neurons and C.
Scientists have found that the protein histone H1.2 and the enzyme PARP1 could be potential therapeutic targets to decrease neurodegeneration in amyotrophic lateral sclerosis (ALS). Amyotrophic ...
The linker histones, H1 and its variant forms ... This led to the prediction that the linker histone may interfere with TFIIIA binding. Figure 2: Diagrams summarizing two alternative models ...
The study was published under the title "ALS-FUS mutations cause abnormal PARylation and histone H1.2 interaction, leading to pathological changes" in Cell Reports. The two proteins that ...
1998). Interestingly, histone H1 is very important in stabilizing chromatin higher-order structures, and 30-nanometer fibers form most readily when H1 is present. Processes such as transcription ...
Epub 2019 Aug 2. Prescott NA and David Y. Utilizing intein trans-splicing for in vivo generation ... A Robust Method for the Purification and Characterization of the Human Histone H1 Variants.